Tempus AI announced a private offering of $350 million in convertible senior notes, with net proceeds planned to repay $307.7 million of existing loans and interest while funding other corporate needs including technology and investment opportunities. The notes are due in 2032, with an option for initial purchasers to add up to $52.5 million. The company said proceeds will also cover deal costs and include general purposes such as working capital and operating expenses. Tempus conducted a similar convertible notes offering last year, selling about $400 million, and subsequently increased the offering size to $650 million. The financing underlines Tempus’ ongoing capital strategy as it scales precision medicine data, diagnostics access, and trial enablement—areas where cash needs can intensify with product and partner expansions.